Earlier quoted context omitted.
In the important areas, it does check itself. If a scientist has been doing some interesting work, she will soon find herself with colleagues working on the same area. If she has not been doing something interesting, that line of research does not get cited, dies out, and does not get funding. In active learning, there's a tradeoff between exploration and exploitation. Science does this too, but heuristically.
Not necessarily true. Ioannidis did a review of 49 studies cited more than 1,000 times in the medical literature -- prime candidates for being replicated or tested by future results. Of those, - 16% were found by later studies to be wrong - 16% were found to have exaggerated the size of effects they claimed to detect - 44% were replicated, and - 24% were unchallenged and unreplicated by later literature. So a full qu…
Regarding the 24%, if you look in Table 2 of that study, of the 12 that were "unchallenged and unreplicated", the notes for 10 list follow on studies that would reveal problems with the initial study, were the initial study to be "wrong."
That leaves 4% that are "unchallenged and unreplicated" yet have 1000 citations. So I would be quite interested to know the take of the researchers in the field on those papers, and if they would agree with Ioannidis' assessment on those 2 papers.